SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000909518-08-000336
Filing Date
2008-04-11
Accepted
2008-04-11 15:57:31
Documents
1
Period of Report
2008-04-09

Document Format Files

Seq Description Document Type Size
1 pfizer_form4ex.html 4  
1 pfizer_form4ex.xml 4 4710
  Complete submission text file 0000909518-08-000336.txt   6904
Mailing Address 235 E 42ND ST NEW YORK NY 10017
Business Address 235 E 42ND ST NEW YORK NY 10017 2125732323
PFIZER INC (Reporting) CIK: 0000078003 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-20117 | Film No.: 08752329
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address 4848 LOOP CENTRAL DRIVE SUITE 700 HOUSTON TX 77081
Business Address 4848 LOOP CENTRAL DRIVE SUITE 700 HOUSTON TX 77081 7137968822
ENCYSIVE PHARMACEUTICALS INC (Issuer) CIK: 0000887023 (see all company filings)

IRS No.: 133532643 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1